These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1504 related items for PubMed ID: 27921263

  • 1. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [Abstract] [Full Text] [Related]

  • 2. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
    Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang T, Huang W, Ni R, Lu C, Zhang X.
    Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
    [Abstract] [Full Text] [Related]

  • 4. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G, Xu Z, Zhang S, Shen Y, Qiu H, Zhu G, He S, Tao T, Chen X.
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [Abstract] [Full Text] [Related]

  • 5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 6. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
    Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.
    J Mol Histol; 2015 Dec 07; 46(6):485-97. PubMed ID: 26438629
    [Abstract] [Full Text] [Related]

  • 7. α7nAChR-mediated recruitment of PP1γ promotes TRAF6/NF-κB cascade to facilitate the progression of Hepatocellular Carcinoma.
    Wan C, Wu M, Zhang S, Chen Y, Lu C.
    Mol Carcinog; 2018 Nov 07; 57(11):1626-1639. PubMed ID: 30074282
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H, Wang J, Yin J, Lu B, Yang Q, Wan Y, Jia C.
    Cell Physiol Biochem; 2018 Nov 07; 45(3):1121-1135. PubMed ID: 29439259
    [Abstract] [Full Text] [Related]

  • 9. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
    Huang W, Cui X, Chen Y, Shao M, Shao X, Shen Y, Liu Q, Wu M, Liu J, Ni W, Lu C, Wan C.
    Pathol Res Pract; 2016 Mar 07; 212(3):171-8. PubMed ID: 26706601
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.
    World J Gastroenterol; 2015 Jul 28; 21(28):8588-604. PubMed ID: 26229401
    [Abstract] [Full Text] [Related]

  • 11. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
    Zhang X, Xu P, Ni W, Fan H, Xu J, Chen Y, Huang W, Lu S, Liang L, Liu J, Chen B, Shi W.
    Pathol Res Pract; 2016 Mar 28; 212(3):162-70. PubMed ID: 26804244
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC.
    Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518
    [Abstract] [Full Text] [Related]

  • 16. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y, Yang S, Hu J, Yu C, He M, Cai Z.
    PLoS One; 2016 Dec 01; 11(5):e0154939. PubMed ID: 27183310
    [Abstract] [Full Text] [Related]

  • 17. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
    Qiu H, Zhang X, Ni W, Shi W, Fan H, Xu J, Chen Y, Ni R, Tao T.
    Dig Dis Sci; 2016 Mar 01; 61(3):795-805. PubMed ID: 26553251
    [Abstract] [Full Text] [Related]

  • 18. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, Chen X, He S.
    Tumour Biol; 2016 Nov 01; 37(11):14615-14628. PubMed ID: 27619678
    [Abstract] [Full Text] [Related]

  • 19. Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma.
    Wang D, Zhang S, Chen Y, Hu B, Lu C.
    Hum Pathol; 2018 Feb 01; 72():80-90. PubMed ID: 29126834
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma.
    Liu J, Cui X, Qu L, Hua L, Wu M, Shen Z, Lu C, Ni R.
    Exp Mol Pathol; 2016 Aug 01; 101(1):58-65. PubMed ID: 27302463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.